Proteon triggers a stock implosion as its first PhIII proves to be a bust
This morning it was Proteon Therapeutics’ $PRTO turn to join the queue of small biotechs to step on a land mine.
The Waltham, MA-based biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
